Jump to main navigation Jump to main navigation Jump to main content Jump to footer content

CompBioMed

Technologie:Supercomputing Forschungsbereich:Visualisation

Funded by the European Union's Horizon programme, 52 universities, companies and research institutes have been working on the digital transformation of medicine and the computer-aided development of new drugs.

 

CompBioMed is a Centre of Excellence focused on the use and development of computational methods for biomedical applications. The research was carried out in two phases from 2016 to 2024.

At the heart of both CompBioMed projects is the Virtual Human, a digital twin of a human being that will help doctors treat patients and speed up the development of drugs and new treatments.

Visualisation of simulation data is also an important part of CompBioMed's Virtual Human. For example, the LRZ has visualised the blood flow in the forearm and the brain, and developed workloads and a toolset that can be used to map similar processes in organisms.

 

Facts & Figures CompBioMed

  • 18 Core-Partners; 52 associated partners
  • 310 science paper, 2 books, 2 films
  • 139 events, 26 workshops
  • Funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 675451 (phase 1) and grant agreement No. 823712 (phase 2).